Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2013, Article ID 793819, 9 pages
http://dx.doi.org/10.1155/2013/793819
Review Article

Preoperative Localization and Surgical Margins in Conservative Breast Surgery

Surgery Division, Department of Clinical Sciences, L. Sacco Hospital, University of Milan, Via G.B. Grassi 74, 20157 Milan, Italy

Received 14 September 2012; Revised 6 June 2013; Accepted 10 July 2013

Academic Editor: A. K. Dcruz

Copyright © 2013 F. Corsi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. E. Singletary, “Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy,” American Journal of Surgery, vol. 184, no. 5, pp. 383–393, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. E. R. Fisher, S. Anderson, C. Redmond, and B. Fisher, “Ipsilaterial breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06,” Seminars in Surgical Oncology, vol. 8, no. 3, pp. 161–166, 1992. View at Google Scholar · View at Scopus
  3. B. Fisher, S. Anderson, J. Bryant et al., “Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer,” The New England Journal of Medicine, vol. 347, no. 16, pp. 1233–1241, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. U. Veronesi, N. Cascinelli, L. Mariani et al., “Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer,” The New England Journal of Medicine, vol. 347, no. 16, pp. 1227–1232, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Gage, S. J. Schnitt, A. J. Nixon et al., “Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy,” Cancer, vol. 9, pp. 1921–1928, 1996. View at Google Scholar
  6. S. J. Schnitt, A. Abner, R. Gelman et al., “The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy,” Cancer, vol. 74, pp. 1746–1751, 1994. View at Google Scholar
  7. C. C. Park, M. Mitsumori, A. Nixon et al., “Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence,” Journal of Clinical Oncology, vol. 18, no. 8, pp. 1668–1675, 2000. View at Google Scholar · View at Scopus
  8. M. E. Peterson, D. J. Schultz, C. Reynolds, and L. J. Solin, “Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience,” International Journal of Radiation Oncology Biology Physics, vol. 43, no. 5, pp. 1029–1035, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Horiguchi, Y. Koibuchi, H. Takei et al., “Breast-conserving surgery following radiation therapy of 50 Gy in stages I and II carcinoma of the breast: the experience at one institute in Japan,” Oncology Reports, vol. 9, no. 5, pp. 1053–1057, 2002. View at Google Scholar · View at Scopus
  10. K. Karasawa, T. Obara, T. Shimizu et al., “Outcome of breast-conserving therapy in the Tokyo women's medical university breast cancer society experience,” Breast Cancer, vol. 10, no. 4, pp. 341–348, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. C. A. Perez, “Conservation therapy in T1-T2 breast cancer: past, current issues, and future challenges and opportunities,” Cancer Journal, vol. 9, no. 6, pp. 442–453, 2003. View at Google Scholar · View at Scopus
  12. R. J. Santiago, L. Wu, E. Harris et al., “Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience,” International Journal of Radiation Oncology Biology Physics, vol. 58, no. 1, pp. 233–240, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Karasawa, M. Mitsumori, C. Yamauchi et al., “Treatment outcome of breast-conserving therapy in patients with positive or close resection margins: Japanese muiti institute survey for radiation dose effect,” Breast Cancer, vol. 12, no. 2, pp. 91–98, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Kreike, A. A. M. Hart, T. van de Velde et al., “Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up,” International Journal of Radiation Oncology Biology Physics, vol. 71, no. 4, pp. 1014–1021, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Houssami, P. Macaskill, M. L. Marinovich et al., “Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy,” European Journal of Cancer, vol. 46, no. 18, pp. 3219–3232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Morrow, J. R. Harris, and S. J. Schnitt, “Surgical margins in lumpectomy for breast cancer—bigger is not better,” The New England Journal of Medicine, vol. 367, pp. 79–82, 2012. View at Google Scholar
  17. J. M. Dixon and N. Houssami, “Bigger margins are not better in breast conserving surgery,” British Medical Journal, vol. 345, Article ID e5855, 2012. View at Google Scholar
  18. B. Fisher, J. Dignam, J. Bryant et al., “Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors,” Journal of the National Cancer Institute, vol. 88, no. 21, pp. 1529–1542, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Fisher, J. Dignam, E. P. Mamounas et al., “Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate and fluorouracil,” Journal of Clinical Oncology, vol. 14, pp. 1982–1992, 1996. View at Google Scholar
  20. P. I. Tartter, I. J. Bleiweiss, and S. Levchenko, “Factors associated with clear biopsy margins and clear reexcision margins in breast cancer specimens from candidates for breast conservation,” Journal of the American College of Surgeons, vol. 185, no. 3, pp. 268–273, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. E. D. Kurniawan, M. H. Wong, I. Windle et al., “Predictors of surgical margin status in breast-conserving surgery within a breast screening program,” Annals of Surgical Oncology, vol. 15, no. 9, pp. 2542–2549, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Reedijk, N. Hodgson, G. Gohla et al., “A prospective study of tumor and technical factors associated with positive margins in breast-conservation therapy for nonpalpable malignancy,” The American Journal of Surgery, vol. 204, pp. 263–268, 2012. View at Google Scholar
  23. H. C. Shin, W. Han, H. G. Moon et al., “Nomogram for predicting positive resection margins after breast-conserving surgery,” Breast Cancer Research and Treatment, vol. 134, pp. 1115–1123, 2012. View at Google Scholar
  24. B. Cady, M. D. Stone, J. G. Schuler, R. Thakur, M. A. Wanner, and P. T. Lavin, “The new era in breast cancer: invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening,” Archives of Surgery, vol. 131, no. 3, pp. 301–308, 1996. View at Google Scholar · View at Scopus
  25. M. J. Silverstein, M. D. Lagios, S. Groshen et al., “The influence of margin width on local control of ductal carcinoma in situ of the breast,” The New England Journal of Medicine, vol. 340, no. 19, pp. 1455–1461, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. U. Rudloff, E. Brogi, A. S. Reiner et al., “The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy,” Annals of Surgery, vol. 251, no. 4, pp. 583–591, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. F. A. Vicini, L. L. Kestin, N. S. Goldstein, K. L. Baglan, J. E. Pettinga, and A. A. Martinez, “Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy,” Journal of Surgical Oncology, vol. 76, no. 4, pp. 245–254, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. S.-Y. Wang, H. Chu, T. Shamliyan et al., “Network meta-analysis of margin threshold for women with ductal carcinoma in situ,” Journal of the National Cancer Institute, vol. 104, no. 7, pp. 507–516, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. J. A. Margenthaler, “Optimizing conservative breast surgery,” Journal of Surgical Oncology, vol. 103, no. 4, pp. 306–312, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. B. O. Anderson, R. Masetti, and M. J. Silverstein, “Oncoplastic approaches to partial mastectomy: an overview of volume-displacement techniques,” Lancet Oncology, vol. 6, no. 3, pp. 145–157, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. S. L. Spear, C. V. Pelletiere, A. J. Wolfe, T. N. Tsangaris, and M. F. Pennanen, “Experience with reduction mammaplasty combined with breast conservation therapy in the treatment of breast cancer,” Plastic and Reconstructive Surgery, vol. 111, no. 3, pp. 1102–1109, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. S. K. Down, P. K. Jha, A. Burger, and M. I. Hussien, “Oncological advantages of oncoplastic breast-conserving surgery in treatment of early breast cancer,” Breast Journal, vol. 19, pp. 56–63, 2013. View at Google Scholar
  33. A. Losken, C. S. Dugal, T. M. Styblo, and G. W. Carlson, “A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique,” Annals of Plastic Surgery, 2013. View at Publisher · View at Google Scholar
  34. G. Canavese, A. Catturich, C. Vecchio et al., “Pre-operative localization of non-palpable lesions in breast cancer by charcoal suspension,” European Journal of Surgical Oncology, vol. 21, no. 1, pp. 47–49, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Ko, B.-K. Han, M. J. Kyung et al., “The value of ultrasound-guided tattooing localization of nonpalpable breast lesions,” Korean Journal of Radiology, vol. 8, no. 4, pp. 295–301, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. M. L. Ruiz-Delgado, J. A. Lòpez-Ruiz, and A. Sàiz-Lòpez, “Abnormal mammography and sonography associated with foreign-body giant-cell reaction after stereotactic vacuum-assisted breast biopsy with carbon marking,” Acta Radiologica, vol. 49, no. 10, pp. 1112–1118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Rose, J. P. Collins, P. Neerhut, C. V. Bishop, and G. B. Mann, “Carbon localisation of impalpable breast lesions,” Breast, vol. 12, no. 4, pp. 264–269, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. D. B. Kopans and C. A. Swann, “Preoperative imaging-guided needle placement and localization of clinically occult breast lesions,” American Journal of Roentgenology, vol. 152, no. 1, pp. 1–9, 1989. View at Google Scholar · View at Scopus
  39. D. B. Kopans, J. E. Meyer, K. K. Lindfors, and S. S. Bucchianeri, “Breast sonography to guide cyst aspiration and wire localization of occult solid lesions,” American Journal of Roentgenology, vol. 143, no. 3, pp. 489–492, 1984. View at Google Scholar · View at Scopus
  40. D. B. Kopans, “Migration of breast biopsy localization wire,” American Journal of Roentgenology, vol. 151, no. 3, pp. 614–615, 1988. View at Google Scholar · View at Scopus
  41. M. S. Sajid, U. Parampalli, Z. Haider, and R. Bonomi, “Comparison of radioguided occult lesion localization (ROLL) and wire localization for non-palpable breast cancers: a meta-analysis,” Journal of Surgical Oncology, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. N. M. A. Krekel, B. M. Zonderhuis, H. B. A. C. Stockmann et al., “A comparison of three methods for nonpalpable breast cancer excision,” European Journal of Surgical Oncology, vol. 37, no. 2, pp. 109–115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. P. L. Giacalone, A. Bourdon, P. D. Trinh et al., “Radioguided occult lesion localization plus sentinel node biopsy (SNOLL) versus wire-guided localization plus sentinel node detection: a case control study of 129 unifocal pure invasive non-palpable breast cancers,” European Journal of Surgical Oncology, vol. 38, no. 3, pp. 222–229, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. I. Thomassin-Naggara, L. Lalonde, J. David, E. Darai, S. Uzan, and I. Trop, “A plea for the biopsy marker: how, why and why not clipping after breast biopsy?” Breast Cancer Research and Treatment, vol. 132, pp. 881–893, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. F. R. Margolin, L. Kaufman, S. R. Denny, R. P. Jacobs, and J. D. Schrumpf, “Metallic marker placement after stereotactic core biopsy of breast calcifications: comparison of two clips and deployment techniques,” American Journal of Roentgenology, vol. 181, no. 6, pp. 1685–1690, 2003. View at Google Scholar · View at Scopus
  46. F. R. Margolin, R. P. Jacobs, S. R. Denny, and J. D. Schrumpf, “Clip placement after sonographically guided percutaneous breast biopsy,” Breast Journal, vol. 9, no. 3, pp. 226–230, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. P. R. Eby, K. E. Calhoun, B. F. Kurland et al., “Preoperative and intraoperative sonographic visibility of collagen-based breast biopsy marker clips,” Academic Radiology, vol. 17, no. 3, pp. 340–347, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Nurko, A. T. Mancino, E. Whitacre, and M. J. Edwards, “Surgical benefits conveyed by biopsy site marking system using ultrasound localization,” American Journal of Surgery, vol. 190, no. 4, pp. 618–622, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. M. A. Gittleman, “Single-step ultrasound localization of breast lesions and lumpectomy procedure,” American Journal of Surgery, vol. 186, no. 4, pp. 386–390, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Luini, S. Zurrida, V. Galimberti, and G. Paganelli, “Radioguided surgery of occult breast lesions,” European Journal of Cancer, vol. 34, no. 1, pp. 204–205, 1998. View at Google Scholar · View at Scopus
  51. S. Monti, V. Galimberti, G. Trifiro et al., “Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology,” Annals of Surgical Oncology, vol. 14, no. 10, pp. 2928–2931, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. R. S. Rampaul, R. D. MacMillan, and A. J. Evans, “Intraductal injection of the breast: a potential pitfall radioisotope occult lesion localization,” British Journal of Radiology, vol. 76, no. 906, pp. 425–426, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Medina-Franco, L. Abarca-Pérez, M. N. García-Alvarez, J. L. Ulloa-Gómez, C. Romero-Trejo, and J. Sepúlveda-Méndez, “Radioguided occult lesion localization (ROLL) versus wire-guided lumpectomy for non-palpable breast lesions: a randomized prospective evaluation,” Journal of Surgical Oncology, vol. 97, no. 2, pp. 108–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. B. D. Fornage, M. I. Ross, S. E. Singletary, and D. D. Paulus, “Localization of impalpable breast masses: value of sonography in the operating room and scanning of excised specimens,” American Journal of Roentgenology, vol. 163, no. 3, pp. 569–573, 1994. View at Google Scholar · View at Scopus
  55. I. C. Bennett, J. Greenslade, and H. Chiam, “Intraoperative ultrasound-guided excision of nonpalpable breast lesions,” World Journal of Surgery, vol. 29, no. 3, pp. 369–374, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. A. J. Potterton, D. J. Peakman, and J. R. Young, “Ultrasound demonstration of small breast cancers detected by mammographic screening,” Clinical Radiology, vol. 49, no. 11, pp. 808–813, 1994. View at Publisher · View at Google Scholar · View at Scopus
  57. L. F. Smith, R. Henry-Tillman, S. Harms et al., “Hematoma-directed ultrasound-guided breast biopsy,” Annals of Surgery, vol. 233, no. 5, pp. 669–675, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Thompson, R. Henry-Tillman, A. Margulies et al., “Hematoma-directed ultrasound-guided (HUG) breast lumpectomy,” Annals of Surgical Oncology, vol. 14, no. 1, pp. 148–156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. F. D. Rahusen, A. H. Taets van Amerongen, P. J. van Diest, P. J. Borgstein, R. P. Bleichrodt, and S. Meijer, “Ultrasound-guided lumpectomy of nonpalpable breast cancers: a feasibility study looking at the accuracy of obtained margins,” Journal of Surgical Oncology, vol. 72, pp. 72–76, 1999. View at Google Scholar
  60. N. M. Krekel, M. H. Haloua, A. M. L. Cardozo et al., “Intraoperative ultrasound guidance for palpable breast cancer excision (COBALT trial): a multicentre, randomised controlled trial,” The Lancet Oncology, vol. 14, pp. 48–54, 2013. View at Google Scholar
  61. K. Esbona, Z. Li, and L. G. Wilke, “Intraoperative imprint citology and frozen section pathology for margin assessment in breast conservation surgery: a systematic review,” Annals of Surgical Oncology, vol. 19, no. 10, pp. 3236–3245. View at Publisher · View at Google Scholar
  62. C. E. Cox, M. Hyacinthe, R. J. Gonzalez et al., “Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in situ: clinical outcome,” Annals of Surgical Oncology, vol. 4, no. 8, pp. 644–649, 1997. View at Google Scholar · View at Scopus
  63. S. L. Blair, J. Wang-Rodriguez, M. J. Cortes-Mateos et al., “Enhanced touch preps improve the ease of interpretation of intraoperative breast cancer margins,” American Surgeon, vol. 73, no. 10, pp. 973–976, 2007. View at Google Scholar · View at Scopus
  64. A. Kobbermann, A. Unzeitig, X.-J. Xie et al., “Impact of routine cavity shave margins on breast cancer re-excision rates,” Annals of Surgical Oncology, vol. 18, no. 5, pp. 1349–1355, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. J. C. Bolger, J. G. Solon, S. A. Khan, A. D. Hill, and C. P. Power, “A comparison of intra-operative margin management techniques in breast-conserving surgery: a standardised approach reduces the likelihood of residual disease without increasing operative time,” Breast Cancer, 2013. View at Publisher · View at Google Scholar
  66. R. Marudanayagam, R. Singhal, B. Tanchel, B. O'Connor, B. Balasubramanian, and I. Paterson, “Effect of cavity shaving on reoperation rate following breast-conserving surgery,” Breast Journal, vol. 14, no. 6, pp. 570–573, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Mook, R. Klein, A. Kobbermann et al., “Volume of excision and cosmesis with routine cavity shave margins technique,” Annals of Surgical Oncology, vol. 19, pp. 886–891, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. E. H. Romond, E. A. Perez, J. Bryant et al., “Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer,” The New England Journal of Medicine, vol. 353, no. 16, pp. 1673–1684, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. A. E. Giuliano, L. McCall, P. Beitsch et al., “Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American college of surgeons oncology group z0011 randomized trial,” Annals of Surgery, vol. 252, no. 3, pp. 426–432, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. V. Galimberti, E. Botteri, C. Chifu et al., “Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?” Breast Cancer Research and Treatment, vol. 131, no. 3, pp. 819–825, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. I. Jatoi, “Surgical margins in lumpectomy for breast cancer,” The New England Journal of Medicine, vol. 367, pp. 1269–1270, 2012. View at Google Scholar
  72. R. Arriagada, M. G. Lê, J.-M. Guinebretière, A. Dunant, F. Rochard, and T. Tursz, “Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients,” Annals of Oncology, vol. 14, no. 11, pp. 1617–1622, 2003. View at Publisher · View at Google Scholar · View at Scopus
  73. G. Curigliano, C. Criscitiello, F. Andrè, M. Colleoni, and A. Di Leo, “Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up?” Ecancermedicalscience, vol. 7, article 299, 2013. View at Publisher · View at Google Scholar
  74. The American Society of Breast Surgeons, “Position statement on breast cancer lumpectomy margins,” 2013, https://www.breastsurgeons.org/statements/PDF_Statements/Lumpectomy_Margins.pdf.
  75. S. W. Phillips, H. Gabriel, C. E. Comstock, and L. A. Venta, “Sonographically guided metallic clip placement after core needle biopsy of the breast,” American Journal of Roentgenology, vol. 175, no. 5, pp. 1353–1355, 2000. View at Google Scholar · View at Scopus